ID   SK-RCS1
AC   CVCL_LK88
DR   Wikidata; Q54954646
RX   PubMed=4170382;
RX   PubMed=4180348;
RX   PubMed=4329447;
RX   PubMed=4894370;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Doubling time: 2-3 days (PubMed=4180348).
CC   Donor information: Established from a patient suffering from 'reticulum cell sarcoma'.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3211; Non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 7
//
RX   PubMed=4170382;
RA   Clarkson B.D. Sr.;
RT   "On the cellular origins and distinctive features of cultured cell
RT   lines derived from patients with leukemias and lymphomas.";
RL   Cancer Res. 27:2483-2488(1967).
//
RX   PubMed=4180348;
RA   Clarkson B.D. Sr., Thorbecke G.J., de Harven E., Miles C.;
RT   "Immunoglobulin synthesis by human reticulum sarcoma cells in vivo and
RT   during long-term culture in vitro.";
RL   Cancer Res. 29:823-836(1969).
//
RX   PubMed=4329447; DOI=10.1084/jem.133.3.454; PMCID=PMC2138946;
RA   Giraldo G., Beth-Giraldo E., Hirshaut Y., Aoki T., Old L.J., Boyse E.A.,
RA   Chopra H.C.;
RT   "Human sarcomas in culture. Foci of altered cells and a common
RT   antigen; induction of foci and antigen in human fibroblast cultures by
RT   filtrates.";
RL   J. Exp. Med. 133:454-478(1971).
//
RX   PubMed=4894370; DOI=10.1002/1097-0142(196908)24:2<211::AID-CNCR2820240202>3.0.CO;2-3;
RA   Southam C.M., Burchenal J.H., Clarkson B.D. Sr., Tanzi A., Mackey R.,
RA   McComb V.;
RT   "Heterotransplantability of human cell lines derived from leukemia and
RT   lymphomas into immunologically tolerant rats.";
RL   Cancer 24:211-222(1969).
//